- Merz Pharma
-
Merz Pharma GmbH & Co. KGaA is an international healthcare company specializing in the research, development and marketing of pharmaceuticals for the treatment of neurological and psychiatric diseases. Based in Frankfurt am Main, Germany, Merz is a leader in the field of Alzheimer's disease research and developed memantine as the first drug for the treatment of moderate to severe Alzheimer's disease. Other franchises covered by Merz are hepatology / metabolic diseases and dermatology (including Mederma scar gel). In Asia Pacific, the Merz franchise covers aesthetic dermatology (including Radiesse and Xeomin).
Merz was founded in 1908, has 1700 employees and had 580 million euros of sales in 2008/09. The US subsidiary of Merz is Merz Pharmaceuticals LLC in Greensboro, North Carolina.
External links
Categories:- Pharmaceutical companies of Germany
- Companies established in 1908
Wikimedia Foundation. 2010.